New Brunswick, N.J. – A Westfield (Union County) resident has been named the new Chief of Gynecologic Oncology at The Cancer Institute of New Jersey. Darlene G. Gibbon, MD, was appointed by Robert S. DiPaola, MD, director of The Cancer Institute of New Jersey. The Cancer Institute of New Jersey is a Center of Excellence of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School (RWJMS).
Dr. Gibbon, who came to CINJ in 2000, completed a fellowship at the State University of New York Health Science Center at Brooklyn and her residency at Albert Einstein College of Medicine in the Bronx. She most recently served as CINJ’s Clinical Director of Gynecologic Oncology and is an expert in gynecologic malignancies and the design and implementation of clinical trials that target ovarian cancer. In addition, Gibbon has received her Board Certification in Hospice and Palliative Care Medicine, one of only a handful of gynecologic oncologists who have done so.
Gibbon, an associate professor of obstetrics, gynecology and reproductive sciences at RWJMS, also has a clinical and research interest in survivorship issues relating to adolescent and young adult cancer patients. She has been called upon for her expertise in this area, having participated in a national progress review group for this population and having presented information at peer forums.
In her new role, Gibbon will have oversight of and responsibility for all clinical, surgical and research objectives in gynecologic oncology. “Since her arrival at CINJ, Dr. Gibbon has educated and successfully met the needs of countless patients while helping to drive gynecologic cancer research. Because of her expertise I have every confidence that CINJ’s Gynecologic Oncology Program will continue to grow,” noted Dr. DiPaola, who also is a professor of medicine at RWJMS.
Gibbon is author or co-author of more than 16 publications. She also serves as a member of the Advisory Boards for the Teal Tea Foundation and Cancer Support Community Central New Jersey, and is a member of the Palliative Care Task Force for the Society of Gynecologic Oncology.
She takes over the position from Lorna Rodriguez, MD, PhD, professor of obstetrics, gynecology and reproductive sciences at RWJMS, who was recently named director of CINJ’s Precision Medicine Initiative.
About The Cancer Institute of New Jersey
The Cancer Institute of New Jersey (www.cinj.org) is the state’s first and only National Cancer Institute-designated Comprehensive Cancer Center dedicated to improving the detection, treatment and care of patients with cancer, and serving as an education resource for cancer prevention. Physician-scientists at The Cancer Institute of New Jersey engage in translational research, transforming their laboratory discoveries into clinical practice, quite literally bringing research to life. To make a tax-deductible gift to support The Cancer Institute of New Jersey, call 732-235-8614 or visit www.cinjfoundation.org. Follow us on Facebook at www.facebook.com/TheCINJ.
The Cancer Institute of New Jersey Network is comprised of hospitals throughout the state and provides the highest quality cancer care and rapid dissemination of important discoveries into the community. Flagship Hospital: Robert Wood Johnson University Hospital. System Partner: Meridian Health (Jersey Shore University Medical Center, Ocean Medical Center, Riverview Medical Center, Southern Ocean Medical Center, and Bayshore Community Hospital). Major Clinical Research Affiliate Hospitals: Carol G. Simon Cancer Center at Morristown Medical Center, Carol G. Simon Cancer Center at Overlook Medical Center, and Cooper University Hospital. Affiliate Hospitals: CentraState Healthcare System, JFK Medical Center, Robert Wood Johnson University Hospital Hamilton (CINJ Hamilton), Somerset Medical Center, The University Hospital/UMDNJ-New Jersey Medical School*, and University Medical Center at Princeton. *Academic Affiliate